20103 ⎘
Medicinal preparations characterised by special physical form; Pills, tablets, discs, rods; Excipients; Inactive ingredients; Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
N-PALMITOYL-ETHANOLAMIDE FOR USE IN THE PREVENTION OF COLORECTAL CARCINOMA
#602LOW-DOSAGE ORODISPERSIBLE OPIOID TABLET AND METHOD FOR PREPARING SAME
#603PHARMACEUTICAL PREPARATION
#604Pharmaceutical compositions
#605Pharmaceutical composition
#606SOLID ORAL DOSAGE FORM COMPRISING NAPROXEN AND VITAMIN B1
#607SOLID ORAL DOSAGE FORM COMPRISING NAPROXEN AND VITAMIN B12
#608IRAK4 degraders and uses thereof
#609BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES
#610AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF
#611AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF
#612Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives
#613Delayed release deferiprone tablets and methods of using the same
#614A METHOD OF MANUFACTURING A PHARMACEUTICAL COMPOSITION COMPRISING NEFOPAM AND ACETAMINOPHEN, AND THE PHARMACEUTICAL COMPOSITION OBTAINED THEREBY
#615METHODS OF TREATING INFECTIONS IN OVERWEIGHT AND OBESE PATIENTS USING ANTIBIOTICS
#616MONOMETHYLFUMARATE PRODRUG COMPOSITIONS
#617Tablet formulation of 2-fluoro-n-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide
#618MODIFIED RELEASE FORMULATION OF A PYRIMIDINYLAMINO-PYRAZOLE COMPOUND, AND METHODS OF TREATMENT
#619IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1-CARBONYL)-4-FLUORO-BENZYL]-2H-PHTHALAZIN-1-ONE
#620TABLETING OF SPECIFIC POLYMER STABILIZERS
#621PHARMACEUTICAL COMPOSITIONS COMPRISING GRANULATED BEMPEDOIC ACID
#622SOLID DOSE FORMULATIONS FOR NEEDLE-FREE DELIVERY
#623Treatment of Abdominal Pain Associated with Diarrhea-Predominant Irritable Bowel Syndrome
#624Pharmaceutical compositions comprising Akt protein kinase inhibitors
#625Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (MGLU5) Antagonists
#626PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HBV
#627Fast dissolving pharmaceutical compositions
#628METHODS OF TREATING VIRALLY ASSOCIATED CANCERS WITH HISTONE DEACETYLASE INHIBITORS
#629PROCASPASE-3 ACTIVATION AND IMMUNOTHERAPY FOR TREATMENT OF CANCER
#630TREATMENTS OF ANGIOEDEMA
#631STABLE HOT-MELT EXTRUDATE CONTAINING VALSARTAN AND SACUBITRIL
#632Pharmaceutical composition comprising axitinib
#633METHOD FOR MANUFACTURING PHARMACEUTICAL PREPARATION
#634Selective small molecule peptidomimetic melanocortin ligands
#635Pharmaceutical Composition Comprising Venetoclax
#636Pharmaceutical compositions comprising Afatinib
#637ORALLY DISINTEGRATING PHARMACEUTICAL COMPOSITIONS OF APIXABAN
#638Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
#639Amorphous solid dispersions
#640Modified or Targeted Release Formulations of Linaclotide
#641ORODISPERSIBLE TABLET
#642SUSTAINED RELEASE COMPOSITION COMPRISING TAPENTADOL OXALATE AND METHOD OF PREPARATION THEREOF
#643EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS OF RIOCIGUAT
#644Tacrolimus for improved treatment of transplant patients
#645FORMULATIONS OF A COMPOUND MODULATING KINASES
#646FORMULATIONS
#647Sustained release compositions of endoxifen
#648MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES
#649SUSTAINED RELEASE COMPOSITION COMPRISING TAPENTADOL AND METHOD OF PREPARATION THEREOF
#650COMPOSITION OF A 5-HT2A SEROTONIN RECEPTOR MODULATOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#651Solid oral nicotine formulation
#652TABLET FOR USE IN TREATING HUNTINGTON'S DISEASE AND METHOD OF MAKING THE SAME
#653ANTICANCER COMPOSITIONS
#654PEPTIDE YY PHARMACEUTICAL FORMULATIONS, COMPOSITIONS, AND METHODS
#655Formulations of a somatostatin modulator
#656High dosage tebipenem pivoxil tablet formulation
#657Pellet and multi-unit pellet system (MUPS)
#658TABLET CONTAINING FERRIC CITRATE
#659Method of Making a Magnesium Salt of an Alpha Keto Acid of Leucine, Isoleucine, and Valine
#660Delayed release methylphenidate compositions
#661Sustained release solid dosage forms for modulating the colonic microbiome
#662Conformal coating of cells for immunoisolation
#663IBUPROFEN AND FAMOTIDINE TABLET
#664PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL 2 FAMILY INHIBITOR
#665Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
#666Immediate release abuse-deterrent granulated dosage forms
#667METHOD FOR MANUFACTURING ORALLY DISINTEGRATING TABLET, AND ORALLY DISINTEGRATING TABLET
#668Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods
#669PRESSURIZED METERED DOSE INHALERS AND METHOD OF MANUFACTURE
#670PHARMACEUTICAL COMPOSITIONS
#671PHARMACEUTICAL COMPOSITIONS
#672PHARMACEUTICAL COMPOSITIONS
#673Methods of treating depression using orexin-2 receptor antagonists
#674CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#675METHOD FOR MANUFACTURING A SOLID ADMINISTRATION FORM AND SOLID ADMINISTRATION
#676Compositions of grapiprant and methods for using the same
#677Opioid receptor modulator dosage formulations
#678Orodispersible dosage unit containing an estetrol component
#679Programmable pharmaceutical compositions for chrono drug release
#680ANTIDIABETIC MEDICATIONS
#681PAC-1 COMBINATION THERAPY
#682PROCESS FOR THE PREPARATION OF EASY-TO-TAKE TABLETS CONTAINING DRY EXTRACT OF GINKGO BILOBA LEAVES
#683ELTROMBOPAG CHOLINE DOSAGE FORMS
#684PHARMACEUTICAL COMPOSITIONS
#685Immediate release abuse-deterrent granulated dosage forms
#686Formulations of a somatostatin modulator
#687LACTOSE POWDER BED THREE DIMENSIONAL PRINTING
#688PYRIDINE DERIVATIVES
#689Solid dosage formulations of an orexin receptor antagonist
#690Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse
#691ABUSE-DETERRENT DOSAGE FORMS CONTAINING ESKETAMINE
#692PHARMACEUTICAL FORMULATIONS OF A HIF HYDROXYLASE INHIBITOR
#693Synergistic medicinal compositions for treating dysfunctional D-serine signaling
#694Opioid receptor modulator dosage formulations
#695Delayed Release Methylphenidate Compositions
#696Low-Dose Stable Formulations of Linaclotide
#697PHARMACEUTICAL COMPOSITIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL) BENZOIC ACID AND ADMINISTRATION THEREOF
#698Amorphous kinase inhibitor formulations and methods of use thereof
#699Use of sublingual dexmedetomidine for the treatment of agitation
#700Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
#701SIP MODULATOR IMMEDIATE RELEASE DOSAGE REGIMEN
#702PHARMACEUTICAL COMPOSITION CONTAINING TAMSULOSIN HYDROCHLORIDE WITH EXCELLENT ACID RESISTANCE AND PREPARATION METHOD THEREFOR
#703Once Daily Formulations Of Tetracyclines
#704Extended Release Highly Loaded Drug Compositions
#705Opioid receptor modulator dosage formulations
#706Tosylacetate based compounds and derivatives thereof as PHGDH inhibitors
#707DISPERSIBLE COMPOSITIONS
#708DELAYED RELEASE PHARMACEUTICAL COMPOSITION OF PREDNISONE AND PREPARATION THEREOF
#709PHARMACEUTICAL PREPARATION
#710SUBSTITUTED 1,2,4-OXADIAZOLE, ITS APPLICATION AND A PHARMACEUTICAL PREPARATION COMPRISING IT
#711Deuterated N,N-dimethyltryptamine compounds
#712Parenteral Formulations of Dopamine Agonists
#713TWO SPEED MONOLITHIC SYSTEM FOR CONTROLLED RELEASE OF DRUGS
#714Laxative tablet
#715Formulation and treatment methods
#716Programmable pharmaceutical compositions for chrono drug release
#717Delayed release deferiprone tablets and methods of using the same
#718Monolithic composition for dual-rate release with high drug loading
#719Methods for the treatment of abnormal involuntary movement disorders
#720Therapeutic solid dosage forms
#721MULTI-CAVITY CUSTOMIZABLE DOSAGE FORMS
#722COMPOSITION THAT FORMS LIQUID CRYSTALLINE PARTICLES
#723Solid forms and methods of preparing the same
#724Pregabalin sustained release composition and method for preparing the same
#725SOLID DOSAGE FORMS WITH HIGH ACTIVE AGENT LOADING
#726Formulations of pyrimidine cyclohexyl glucocorticoid receptor modulators
#727Oral dosage form
#728DUAL RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMBINATION OF A BETA-3 ADRENORECEPTOR AGONIST AND A MUSCARINIC RECEPTOR ANTAGONIST
#729PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
#730PHARMACEUTICAL COMPOSITIONS OF 5-HT6 RECEPTOR ANTAGONIST
#731Compositions of matter and pharmaceutical compositions
#732Methods of using nitric oxide donor compounds for treatment of COVID-19 and other infectious diseases
#733COMPOUNDS FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION
#734Compounds for the treatment of clostridium difficile infection
#735Oral compositions of MK2 pathway inhibitor for treatment of immune conditions
#736Sustained release compositions of 4-aminopyridine
#737Methods and compositions for self-regulated release of active pharmaceutical ingredient
#738ORAL SOLID FORMULATION CONTAINING IRINOTECAN AND METHOD OF PREPARING THE SAME
#739BINDER
#740Ivosidenib forms and pharmaceutical compositions
#741PHARMACEUTICAL COMPOSITION COMPRISING LICARBAZEPINE ACETATE
#742STABILIZED FORMULATIONS OF CNS COMPOUNDS
#743Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or its salt
#744Methods of Treating Cancers, Immune and Autoimmune Diseases, and Inflammatory Diseases Based on BTK Occupancy and BTK Resynthesis Rate
#745Misoprostol dispersible tablet
#746Tamper-resistant drug dosage forms and methods of making and use thereof
#747NOVEL PHARMACEUTICAL FORMULATIONS
#748SOLID DOSAGE FORMS OF PALBOCICLIB
#749PEPTIDE YY PHARMACEUTICAL FORMULATIONS, COMPOSITIONS, AND METHODS
#750MODIFIED RELEASE PREPARATIONS CONTAINING OXCARBAZEPINE AND DERIVATIVES THEREOF
#751Solid dispersion comprising an anticancer compound for improved solubility and efficacy
#752PHARMACEUTICAL COMPOSITIONS WITH A CDC7 INHIBITOR
#753Solid drug tablets for implantable drug delivery devices
#754Controlled release formulation comprising flavoxate
#755PHARMACEUTICAL COMPOSITION FOR AMELIORATION OF ADVERSE SIDE EFFECTS
#756COMPOUNDS AND METHODS FOR TREATING FUNGAL INFECTIONS
#757PHARMACEUTICAL COMPOSITION CONTAINING POORLY-SOLUBLE BASIC MEDICINE
#758DRUG DELIVERY SYSTEM
#759Gastro-resistant formulation containing posaconazole
#760PHARMACEUTICAL DOSAGE FORM WHICH CAN BE ADMINISTERED ORALLY AND HAS MODIFIED RELEASE
#761HIGH DRUG LOAD SOLID ORAL DOSAGE FORMS OF DEXAMETHASONE
#762Compounds comprising tricyclic heterocyclic compounds
#763PHOSPHODIESTERASE-5 INHIBITOR COMBINATIONS, METHODS OF MAKING, AND METHODS OF USE THEREOF
#764Methods for the treatment of abnormal involuntary movement disorders
#765DPP IV inhibitor formulations
#766METHODS OF TREATMENT FOR ALPHA-1 ANTITRYPSIN DEFICIENCY
#767Compositions and treatment procedures for the treatment of pathogenic infections
#768SUBSTITUTED TRIAZOLE DERIVATIVES AND USES THEREOF
#769Solid preparation composition for oral administration of colonic purgative containing anhydrous sodium sulfate, potassium sulfate, anhydrous magnesium sulfate and simethicone
#770PREGABALIN EXTENDED-RELEASE FORMULATIONS
#771Poly(meth)acrylic acid popcorn polymerizates as disintegrants for tablets
#772TABLET CONTAINING ANTITUMOR AGENT
#773Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2
#774PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN, PROCESSES FOR THEIR OBTAINMENT AND METHOD OF TREATING INTESTINAL DISEASE
#775RAPID SET GEL CONCENTRATE FOR MEDICAL PRODUCTS
#776Modified release preparations containing oxcarbazepine and derivatives thereof
#777Extended release compositions comprising pyridostigmine
#778COMPOSITIONS FOR TREATING CYSTIC FIBROSIS
#779EXTENDED RELEASE COMPOSITIONS AND PROCESS FOR PREPARATION
#780Programmable pharmaceutical compositions for chrono drug release
#781ORALLY DISINTEGRATING PHARMACUTICAL COMPOSITION COMPRISING NEFOPAM AND PROCESS FOR PREPARING THE SAME
#782SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR
#783Pharmaceutical combination, composition and compound preparation containing glucokinase activator and K-ATP channel blocker, preparation method therefor and use thereof
#784CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#785PHARMACEUTICAL COMPOSITION COMPRISING AMORPHOUS SUNITINIB
#786Pharmaceutical combination, composition, and combination preparation comprising glucokinase activator and SGLT-2 inhibitor and preparation methods and uses thereof
#787Methylphenidate extended release chewable tablet
#788Metaxalone formulations
#789Pharmaceutical combination containing glucose kinase activator and PPAR receptor activator, composition, compound preparation method for same, and uses thereof
#790Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
#791Opioid receptor modulator dosage formulations
#792Opioid receptor modulator dosage formulations
#793Formulations of (R)-2-amino-3-phenylpropyl carbamate
#794ORAL DRUG DOSAGE FORM COMPRISING DRUG IN THE FORM OF NANOPARTICLES
#795BIOAVAILABLE ORAL DOSAGE FORMS
#796NOVEL PHARMACEUTICAL FORMULATIONS
#797Programmable pharmaceutical compositions for chrono drug release
#798USE OF TREZASTILBENOSIDE IN MANUFACTURE OF PRODUCT FOR TREATING AND/OR PREVENTING NON-ALCOHOLIC FATTY LIVER DISEASE
#799DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION
#800Amorphous kinase inhibitor formulations and methods of use thereof
#801Pharmaceutical combination and composition, and combination preparation containing glucokinase activator and biguanide hypoglycemic drug as well as preparation method and use thereof
#802Pharmaceutical combination, composition and compound preparation comprising glucokinase activator and DPP-IV inhibitor, and preparation method and use thereof
#803Compressible Cannabinoid Pharmaceutical Composition
#804Pharmaceutical composition containing quinoline derivative
#805Composition of fused tricyclic gamma-amino acid derivatives and the preparation thereof
#806Acetaminophen preparation, and method for producing same
#807Benzylamino substituted quinazolines and derivatives as SOS1 inhibitors
#808Core tablet composite preparation comprising mosapride and rabeprazole
#809Fast disintegrating cannabinoid tablets
#810FORMULATIONS/COMPOSITIONS COMPRISING A BTK INHIBITOR
#811TAMPER RESISTANT DOSAGE FORMS
#812Tablet dosage form for buccal absorption of active ingredients
#813MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES
#814SOLID ORAL DOSAGE FORMS OF ESLICARBAZEPINE
#815LACTOBACILLUS PLANTARUM COMPOSITIONS AND USES THEREOF
#816Ceritinib Formulation
#817METHODS OF PREPARING EXTRUDATES
#818Substituted oxopyridine derivative
#819Methods for the treatment of abnormal involuntary movement disorders
#820HS-25 tablet and preparation method therefor
#821PREPARATION CONTAINING 6,7-UNSATURATED-7-CARBAMOYL MORPHINAN DERIVATIVES
#822FAST DISINTEGRATING TABLET
#823PROCESS FOR PREPARING AN ORAL DISINTEGRATING DOSAGE FORM
#824Pharmaceutical compositions
#825PHARMACEUTICAL COMPOSITIONS OF SITAGLIPTIN
#826Bacterial efflux pump inhibitors
#827Pharmaceutical compositions
#828Pharmaceutical compositions
#829Synergistic nutritional neuroprotective compositions for ameliorating neural dysfunction
#830Procaspase 3 activation by combination therapy
#831SUSTAINED RELEASE PYRIDOSTIGMINE COMPOSITIONS
#832Pyridine and pyrazine derivatives as preferential cannabinoid 2 agonists
#833PHARMACEUTICAL SOLID PREPARATION COMPRISING BENZAZEPINES AND PRODUCTION METHOD THEREOF
#834Tablet Formulation of 2-Fluoro-N-Methyl-4-[7-(Quinolin-6-Ylmethyl) Imidazo [1,2-B] [1,2,4] Triazin-2-YL] Benzamide
#835Pharmaceutical composition, comprising polmacoxib and pregabalin, for treatment of pain
#836Methods and compositions for treating retina-associated disease using CCR3-inhibitors
#837Pharmaceutical composition comprising eluxadoline, process of preparation and use thereof
#838Ion-Exchange Composition With Water-Soluble Mucoadhesive Polymers
#839POSITION-SPECIFIC ASYMMETRIC DEUTERIUM ENRICHED CATECHOLAMINE DERIVATIVES AND MEDICAMENTS COMPRISING SAID COMPOUNDS
#840PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL 2 FAMILY INHIBITOR
#841Methylphenidate extended release chewable tablet
#842Compound to treat Sjogren's Syndrome
#843USE OF FERRIC CITRATE IN PREVENTION AND/OR TREATMENT OF IRON-DEFICIENCY ANEMIA IN HYPERMENORRHEA PATIENT AND/OR PATIENT SUFFERING FROM HYPERMENORRHEA-ASSOCIATED GYNECOLOGIC DISEASE
#844Orally Disintegrated Tablet Comprising Carbamate Compound
#845Immediate release abuse-deterrent granulated dosage forms
#846SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE
#847Tablet formulation for CGRP active compounds
#848Pharmaceutical formulation
#849STABLE HOT-MELT EXTRUDATE CONTAINING VALSARTAN AND SACUBITRIL
#850DOSAGE FORMS WITH DESIRED RELEASE PROFILES AND METHODS OF DESIGNING AND MAKING THEREOF
#851ABUSE DETERRENT COMPOSITIONS AND METHODS OF MAKING SAME
#852N-(2-(substituted-naphth-1-yl)ethyl) substituted amide compound, preparation and uses thereof
#853IMMEDIATE-RELEASE PHARMACEUTICAL COMPOSITIONS CONTAINING KETOPROFEN LYSINE SALT
#854PHARMACEUTICAL SOLID PREPARATION COMPRISING BENZAZEPINES AND PRODUCTION METHOD THEREOF
#855Method for preparing granules
#856Method for treating cancer
#857Pharmaceutical compositions comprising Ibrutinib
#858CYCLIC ORALLY DISINTEGRATING TABLET
#859Methods of treating depression using orexin-2 receptor antagonists
#860Pharmaceutical Compositions Of Metabotropic Glutamate 5 Receptor (MGLU5) Antagonists
#861Sustained release solid dosage forms for modulating the colonic microbiome
#862Tacrolimus for improved treatment of transplant patients
#863Tacrolimus for improved treatment of transplant patients
#864MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES
#865MODIFIED RELEASE PREPARATIONS CONTAINING OXCARBAZEPINE AND DERIVATIVES THEREOF
#866Methylphenidate extended release chewable tablet
#867Conformal coating of cells for immunoisolation
#868Opioid receptor modulator dosage formulations
#869Intestinal alkaline phosphatase formulations
#870Programmable pharmaceutical compositions for chrono drug release
#871Dextromethorphan extended release pharmaceutical composition
#872Pharmaceutical composition and administrations thereof
#873Solid Pharmaceutical Compositions for Treating HCV
#874COMPOSITIONS FOR DELIVERY OF REBOXETINE
#875Fixed dose combination tablet formulation of acarbose and metformin and process for producing the same
#876Beta-lactamase formulations and uses thereof
#877IMIDAZOTETRAZINE COMPOUNDS
#878Pharmaceutical composition and preparation method therefor and uses thereof
#879Controlled-release tablets, method of making, and method of use thereof
#880Tamper resistant dosage forms
#881Tamper resistant dosage forms
#882Tamper resistant dosage forms
#883Solid drug tablets for implantable drug delivery devices
#884Treatment of diabetes mellitus
#885FORMULATIONS OF RIFAXIMIN AND USES THEREOF
#886FORMULATIONS OF AZAINDOLE COMPOUNDS
#887A STABLE PHARMACEUTICAL COMPOSITION OF POORLY SOLUBLE NONSTEROIDAL ANTIANDROGENS
#888COMPOSITION OF A 5-HT2A SEROTONIN RECEPTOR MODULATOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
#889Instant release pharmaceutical preparation of anticoagulant and preparation method therefor
#890Abuse-proofed oral dosage form
#891Preparation containing benzimidazole derivative
#892Tamper resistant pharmaceutical formulations
#893Ribociclib Tablet
#894Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carb oxamide and solid state forms thereof
#895Extended release compositions comprising pyridostigmine
#896Methods and compositions for self-regulated release of active pharmaceutical ingredient
#897METHOD FOR PRODUCING TABLET
#898COMBINATION FORMULATION CONTAINING SUSTAINED RELEASE METFORMIN AND IMMEDIATE RELEASE HMG-COA REDUCTASE INHIBITOR
#899Controlled-release preparation
#900Gastroretentive treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease